Standard BioTools

company

About

Standard BioTools is a biotech tools company that creates microfluidic-based chips and instrumentation for biological research.

  • 251 - 500

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$7.50M
Industries
Biotechnology,Genetics,Life Science
Founded date
Jan 1, 1999
Number Of Employee
251 - 500
Operating Status
Active

Standard BioTools, previously known as Fluidigm, is driven by a bold vision – unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the Company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$109.50M
Standard BioTools has raised a total of $109.50M in funding over 2 rounds. Their latest funding was raised on Nov 19, 2009 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 19, 2009 Series Unknown $7.50M 2 Detail
Jan 8, 2007 Series E $37M 1 Detail
Sep 9, 2005 Series D $10M 1 Detail
Jan 6, 2004 Series D $21M 1 Detail
Nov 12, 2001 Series C $34M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Standard BioTools is funded by 2 investors. Fidelity Contrafund and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Fidelity Contrafund Series Unknown
Versant Ventures Series Unknown